Achievements
- Co-founded Altay Therapeutics, Y Combinator W20 backed, focused on liver diseases
- Led development of Esbriet (Pirfenidone), FDA-approved lung fibrosis drug, over $6B revenue
- Held leadership roles at Teva Pharmaceuticals and InterMune, deep pharma experience
- Academic credentials from Akdeniz University and Indiana University
- Focused on creating disease-modifying therapies targeting fibrosis and transcription factors
- Part of Nalo Therapeutics, continuing biotech innovation
Can we talk about Osman Ozes
Look, here’s the real scoop on Osman Ozes. This guy’s the real deal in biotech and startups. He’s a YC W20 alum, so he’s been in the game for a minute, crushing it in the healthcare space. His story? Straight fire.
So, Osman’s background is wild. He’s been around some heavy hitters, Teva, InterMune, Indiana University, Akdeniz University, getting deep into drug research and development. The dude’s got serious academic creds and hands-on experience in pharma. That’s the foundation of his hustle.
Now, here’s where it gets really interesting. Osman co-founded Altay Therapeutics, which is backed by Y Combinator, basically the startup world’s stamp of approval. Altay’s all about fighting liver diseases, stuff like fibrosis and liver cancer, using small molecule drugs. Think about that: he’s jumping into some of the toughest diseases to crack, aiming to actually reverse damage, not just treat symptoms. That’s some advanced ambition.
Got a startup idea and seeking investment? No Cap is the first AI investor capable of investing in startups by herself.
Talk to herOsman’s no random rookie trying to start a company. He’s got a legit track record that hits hard. Before Altay, he led the charge on Esbriet (Pirfenidone), the first FDA-approved drug for lung fibrosis. That thing crushed it, over $6 billion in revenue. This guy knows how to turn science into blockbuster meds. It’s about making real, tangible impact and stacking serious cash, not just tossing around ideas.
What does that say about him? Osman’s motivation is clear, he’s driven by a deep desire to actually change lives. He’s not in it for the fame or the money (though those come as a bonus). He’s about tackling the hardest diseases, pushing the limits of what medicine can do. He’s like a scientist who’s also a startup founder, blending hardcore research with a hunger to make shit happen.
His process? It’s all about taking knowledge from the lab and turning it into real-world solutions that save lives. Starting Altay isn’t just another project; it’s a leap into the future of medicine. Osman’s been around enough to see what works and what doesn’t, and he’s not afraid to jump into the deep end. His experience at top pharma companies gave him the inside scoop, and now he’s applying that to startups that could actually change the game.
In short? Osman Ozes is a legit scientist turned biotech founder who’s been behind some of the biggest pharma wins and is now steering his own ship to fight the most stubborn diseases out there. When you hear about him, think of someone who’s not just about the science, he’s about making a real difference, pushing boundaries, and not settling for bullshit. That’s why he’s so important.
Experience
Industries
Sources to check more about Osman Ozes
- [PDF] Real Estate Term Sheet Template - former-students.imperial.edu
- Altay Therapeutics - aVenture Company Research
- Osman Ozes Email & Phone Number | Altay Therapeutics Founder ...
- [PDF] Merchants Struggle to Survive, Thrive, During Historic Challenge
- Healthcare Startups funded by Y Combinator (YC) in San Francisco ...

Select your comment type:
If something is wrong about Osman Ozes, there's inaccurate information or there are updates, please let us know, we'll update it for you and everyone ;)